News

Results From Amgen's Phase 2 Obesity Study Of Monthly Maritide Presented At The American Diabetes Association 85th Scientific Sessions
MariTide, the First Monthly or Less Frequently Dosed Obesity Treatment, Demonstrated Up to ~20% Average Weight Loss Without a Weight Loss Plateau, and Delivered Significant ...